DxLab
DxLab Inc. develops rapid and accurate diagnostic solutions focused on infectious disease testing. Their key product, DxHub, is a standalone point-of-care molecular testing system that delivers PCR-quality results in as little as 10 minutes, capable of running multiple samples on-demand without batching. The platform combines patent-pending isothermal nucleic acid amplification chemistry with machine learning-based design optimizations to create fast, accurate, and affordable infectious disease tests. DxLab targets high patient volume settings with a compact device that can run up to 8 samples simultaneously, aiming to improve disease management and reduce spread. The company has traction including a $1.25 million contract with the U.S. Air Force to adapt DxHub for rapid infectious disease diagnostics at the point-of-care.
DxLab
DxLab Inc. develops rapid and accurate diagnostic solutions focused on infectious disease testing. Their key product, DxHub, is a standalone point-of-care molecular testing system that delivers PCR-quality results in as little as 10 minutes, capable of running multiple samples on-demand without batching. The platform combines patent-pending isothermal nucleic acid amplification chemistry with machine learning-based design optimizations to create fast, accurate, and affordable infectious disease tests. DxLab targets high patient volume settings with a compact device that can run up to 8 samples simultaneously, aiming to improve disease management and reduce spread. The company has traction including a $1.25 million contract with the U.S. Air Force to adapt DxHub for rapid infectious disease diagnostics at the point-of-care.